News Teva's Trisenox approved in first line for APL First ever chemotherapy-free regimen for rare leukaemia.
Views & Analysis Digital Health Round-up: Teva looks to AI for drug repurposi... A round-up of this week’s top digital healthcare news. Marco Ricci reports.
News Teva and IBM Watson team up for drug repurposing New three-year deal will use Watson to discover new indications for existing drugs.
News Teva buys US rights to Celltrion biosimilars Israeli firm buys rights to near-copies of Roche blockbusters.
News Isomorphic Labs raises $5bn in massive third round In yet another sign of the appetite for AI companies among investors, Isomorphic Labs has raised a whopping $5bn in a Series C financing.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.